Search: onr:"swepub:oai:DiVA.org:umu-224959" >
Sequelae treatment ...
Sequelae treatment needs following peripheral facial palsy : retrospective analysis of 525 patients
-
- Ohm, Rebecka (author)
- Karolinska Institutet,Department of Otorhinolaryngology, Karolinska University Hospital, Clintec, Karolinska Institute, Stockholm, Sweden
-
- Stark, Birgit (author)
- Karolinska Institutet,Department of Reconstructive Plastic Surgery, Karolinska University Hospital, Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden
-
- Brännström, Fredrik (author)
- Umeå universitet,Institutionen för kirurgisk och perioperativ vetenskap,Department of Surgery, Capio S:t Görans Hospital, Stockholm, Sweden
-
show more...
-
- Marsk, Elin (author)
- Department of Otorhinolaryngology, Karolinska University Hospital, Clintec, Karolinska Institute, Stockholm, Sweden
-
show less...
-
(creator_code:org_t)
- Lippincott Williams & Wilkins, 2024
- 2024
- English.
-
In: Otology and Neurotology. - : Lippincott Williams & Wilkins. - 1531-7129 .- 1537-4505. ; 45:5, s. E450-E456
- Related links:
-
https://urn.kb.se/re...
-
show more...
-
https://doi.org/10.1...
-
http://kipublication...
-
show less...
Abstract
Subject headings
Close
- Objective: This study uses retrospective longitudinal data from a large unselected cohort of patients with peripheral facial paralysis to determine the prevalence and patient characteristic predictors of sequelae receiving intervention.Study Design: Retrospective case review.Setting: Karolinska University Hospital in Stockholm Sweden serves as the only tertiary facial palsy center in the region. Here, patients are diagnosed, are followed up, and undergo all major interventions.Patients: All adult patients presenting with peripheral facial palsy due to idiopathic, zoster, or Borrelia origin at Karolinska, January 1, 2010 to December 31, 2011 with follow-up until December 2022.Interventions: Patient charts were studied to identify patient characteristics, etiology, initial treatment, severity of palsy, and treatments targeting sequelae.Main Outcome: Measures Types of initial and late treatments were noted. Sunnybrook and/or House-Brackmann scales were used for palsy grading.Results: Five hundred twenty-five patients were included. Thirty-three patients (6.3%) received botulinum toxin injections and/or surgical treatment. In this subgroup, 67% received corticosteroids compared to 85% of all patients (p = 0.005), cardiovascular disease prevalence was higher (23 and 42%, respectively, p = 0.009). For 81 patients (15%), follow-up was discontinued although the last measurement was Sunnybrook less than 70 or House-Brackmann 3 to 6.Conclusions: Of patients with peripheral facial palsy, 6.3% underwent injections and/or surgical treatment within 12 years. However, due to a rather large proportion not presenting for follow-up, this might be an underestimation. Patients receiving late injections and/or surgical treatment had more comorbidities and received corticosteroid treatment to a significantly lower extent in the acute phase of disease.
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Kirurgi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Surgery (hsv//eng)
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Oto-rhino-laryngologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Otorhinolaryngology (hsv//eng)
Keyword
- Bell's palsy
- Botox treatment
- Corticosteroid treatment
- Peripheral facial palsy
- Synkinesis
Publication and Content Type
- ref (subject category)
- art (subject category)
Find in a library
To the university's database